Sonoma Pharma Seals Pricing and Distribution Arrangement, Spiking Share Prices
Sonoma Pharmaceuticals has announced that it has locked in a distribution and pricing deal with the Defense Logistics Agency. The announcement of the deal, which covers its Microcyn Rx products, was followed by Sonoma’s shares jumping in price by 82%. Products included in the deal are used for wound care, eye health, and dermatology.
The Past, Present, and Future of 340B Drug Pricing
As the 340B Drug Pricing Program reaches its 30th year, its successes and failures have come into sharp relief. Tim [...]
Sanofi Transfers Late-Drugs to New Neuro and Psychedelic Biotech Startup
Sanofi has partnered with Terran Biosciences, a small New York biotech, to work on two late-stage neurological and psychiatric drugs. [...]
Amgen’s Biosimilar of Stelara Shows Promising Preliminary Results
New preliminary results show that Amgen’s biosimilar ABP 654 is effective in reducing psoriasis symptoms. ABP 654 is a biosimilar [...]
Canadian Government Drops Plans for Regulatory Factors and Mandatory Net Price Reporting
Planned amendments to Canada’s Patented Medicines Regulations were dropped this week, according to a statement from the Minister of Health. [...]
Health Affairs Podcast: Why Some Medicare Beneficiaries Aren’t Filling Specialty Drug Rxs
As prescription drug prices rise, many patients are forgoing life-saving medications – even when they have insurance. Analysis by the [...]
Drugmakers Commit to Reducing Drug Launch Times in the EU
Members of the European Federation of Pharmaceutical Industries and Associations (EFPIA) have pledged to file for pricing and reimbursement in [...]
Conference: Pharma & Patient 2022
The changing relationship between pharma and patients will be explored at Pharma & Patient 2022 from November 8th-9th in Philadelphia, [...]
AMR Action Fund Makes First Investment to Tackle Antibiotic Resistance
Antimicrobial resistance is a growing problem that has led to the emergence of bacteria resistant to most, if not all, [...]
NPPA Announces Highest Price Hike in Agency’s History
India’s National Pharmaceutical Pricing Authority (NPPA) has announced a price hike of 10.8%, the highest in the nation’s history. The [...]
Blog Post Highlights Impact Coronavirus Could Have on New Drug Launches
A recent blog post on Tribeca Knowledge outlines some of the key challenges pharmaceutical companies face regarding drug launches in [...]
Integration of Novel Diagnostics into Clinical Practice
By John Schneider, Ph.D Similar to drug and device markets, a critical part of the success of novel [...]
